This book was first published in 2004 and appears to have been comprehensively updated to the present day. It aims to cover anything you want to know about cannabis sativa, its neuroscience, epidemiology, psychoactivity, and how it causes, intensifies, and perhaps ameliorates, mental illnesses. It does so in a carefully detailed and remarkably balanced manner, seeking every possible explanation for the many questions it raises and never moralizing about "reefer madness" nor overly lauding the positive effects. One issue that is not addressed is that of legalization, though it seems there is no higher incidence of cannabis-induced psychosis in the Netherlands where marijuana is legal.
There are 21 chapters, with authors from the United Kingdom, United States, Australia, Ireland, Spain, Israel, the Netherlands, Germany, and France. There are no Canadian-chapter authors but this copiously referenced book has many Canadian references. Early chapters deal with neuroscience, which is very complex as the plant produces more than 100 cannabinoids. Tetrahydrocannabinol (THC) is the psychoactive constituent that one takes to get high. It is also the chemical that may make someone become psychotic or intensify psychosis for those already ill. The book explains how cannabis now has to be seen differently with the cultivation of sinsemilla (skunk or nederwiet), which comes from the buds of unfertilized female plants. In Canada 30 years ago, cannabis had less than 1% THC. It reached 10% by 2004. These figures are based on border seizures. In the Netherlands, the average potency reached over 20% in 2003, although it has since dropped a little.
The clinical issues raised are fascinating and complex. There is absolutely no doubt that cannabis users have more psychosis than nonusers and that people with schizophrenia who use marijuana have more relapses than those who do not. Why this happens is unclear but if you read this book you will be able to make up your own mind after considering the various theories and the arguments for each. For example, the question is raised as to which group of patients with schizophrenia has the best outcome: those who never used, those who used and quit, or those who used and continue to do so. The answer is those who used and quit and one has to consider why this is so. Did they have less vulnerability and only became psychotic because of using marijuana and are therefore more likely to have their illness remit so long as they abstain? That seems likely, although one possibility that the authors did not consider was that the good outcome group were actually bipolar but appeared schizophrenic because of the psychotogenic effect of THC.
A significant area of interest is that some cannabis has less THC and more cannabidiol, which is a compound that does not cause psychosis and may account for the claimed beneficial effects of marijuana. An Israeli firm called Tikun Olam has produced an extract that is 16% cannabidiol and less than 1% THC, which is claimed to be antiinflammatory. Medical marijuana is already used in some countries for pain, Parkinson disease, posttraumatic stress disorder, Crohn disease, and multiple sclerosis.
The authors are authoritative and, although some of the material is difficult to absorb if you are not a neurochemist, it is well written. However, there is inevitable repetition as different authors use the same references. It is clearly printed. I was surprised when I found cannabinoid misspelled in the second paragraph of the Preface, which led me to being more surprised that I never found another typo. The price is reasonable for such a book. Because it covers such a broad span of topics, there will be parts of this book that will be less interesting to clinicians and parts that will be less fascinating to basic scientists. 2012;57(11):713-714 
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